These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 8828504

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner.
    Sasaoka T, Ishihara H, Sawa T, Ishiki M, Morioka H, Imamura T, Usui I, Takata Y, Kobayashi M.
    J Biol Chem; 1996 Aug 16; 271(33):20082-7. PubMed ID: 8702728
    [Abstract] [Full Text] [Related]

  • 3. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts.
    Takahashi Y, Tobe K, Kadowaki H, Katsumata D, Fukushima Y, Yazaki Y, Akanuma Y, Kadowaki T.
    Endocrinology; 1997 Feb 16; 138(2):741-50. PubMed ID: 9003010
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling.
    Kim B, Cheng HL, Margolis B, Feldman EL.
    J Biol Chem; 1998 Dec 18; 273(51):34543-50. PubMed ID: 9852124
    [Abstract] [Full Text] [Related]

  • 6. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
    Cousin SP, Hügl SR, Myers MG, White MF, Reifel-Miller A, Rhodes CJ.
    Biochem J; 1999 Dec 15; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
    [Abstract] [Full Text] [Related]

  • 7. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis.
    Sasaoka T, Ishiki M, Wada T, Hori H, Hirai H, Haruta T, Ishihara H, Kobayashi M.
    Endocrinology; 2001 Dec 15; 142(12):5226-35. PubMed ID: 11713219
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.
    Valverde AM, Lorenzo M, Pons S, White MF, Benito M.
    Mol Endocrinol; 1998 May 15; 12(5):688-97. PubMed ID: 9605931
    [Abstract] [Full Text] [Related]

  • 10. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
    Guvakova MA, Surmacz E.
    Cancer Res; 1997 Jul 01; 57(13):2606-10. PubMed ID: 9205064
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
    Liang L, Zhou T, Jiang J, Pierce JH, Gustafson TA, Frank SJ.
    Endocrinology; 1999 May 01; 140(5):1972-83. PubMed ID: 10218944
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mechanism of SHIP-mediated inhibition of insulin- and platelet-derived growth factor-stimulated mitogen-activated protein kinase activity in 3T3-L1 adipocytes.
    Sharma PM, Son HS, Ugi S, Ricketts W, Olefsky JM.
    Mol Endocrinol; 2005 Feb 01; 19(2):421-30. PubMed ID: 15486046
    [Abstract] [Full Text] [Related]

  • 19. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
    Mur C, Valverde AM, Kahn CR, Benito M.
    Diabetes; 2002 Mar 01; 51(3):743-54. PubMed ID: 11872675
    [Abstract] [Full Text] [Related]

  • 20. High affinity IgG receptor activation of Src family kinases is required for modulation of the Shc-Grb2-Sos complex and the downstream activation of the nicotinamide adenine dinucleotide phosphate (reduced) oxidase.
    Park RK, Erdreich-Epstein A, Liu M, Izadi KD, Durden DL.
    J Immunol; 1999 Dec 01; 163(11):6023-34. PubMed ID: 10570290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.